Print
Email
SaveHealthline's Premium Tools
Symptom Search
Discover possible causes based on the symptoms you enter. It's fast, convenient and easy to use.
Discover possible causes based on the symptoms you enter. It's fast, convenient and easy to use.
Healthline Part D Plan Selector
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
 |
Chronic lymphocytic leukemia (CLL) is a cancer of white blood cells. In CLL, mature white blood cells of certain types called lymphocytes function abnormally and cause disease.
|
|
Alemtuzumab is sold as Campath in the United States. Alemtuzumab is a humanized monoclonal antibody that selectively binds to CD52, a protein found on the surface of normal and malignant B and T cells, and that is used to reduce the numbers of circulating malignant cells of patients who have B-cell chronic lymphocytic leukemia (B-CLL).
|
|
Alemtuzumab is sold as Campath in the United States. Alemtuzumab is a humanized monoclonal anti-body that selectively binds to CD52, a protein found on the surface of normal and malignant B and T cells, that is used to reduce the numbers of circulating malignant cells of patients who have B-cell chronic lymphocytic leukemia (B-CLL).
|
|
Antineoplastic agent; recombinant DNA-derived humanized anti-CD52 monoclonal antibody (Campath-1H).
|
|
Alemtuzumab is an antibody made from animal DNA.
|
|
Chlorambucil (marketed under the brand name Leukeran) is a chemotherapy medicine used to treat cancer by interfering with the growth of cancer cells. Purpose Chlorambucil is approved by the Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia and malignant lymphomas.
|
|
Antineoplastic agent; nitrogen mustard derivative; alkylating agent.
|
|
Cladribine, also known by the brand name Leustatin, is a chemotherapy medicine used to treat certain types of cancer by destroying cancerous cells. Purpose Cladribine is approved by the Food and Drug Administration (FDA) to treat active hairy cell leukemia .
|
|
Antineoplastic agent and immunosuppressant; nitrogen mustard-derivative alkylating agent.
|
|
Cyclophosphamide is an anticancer (antineoplastic) agent. It also acts as a suppressor of the immune system.
|
|
Cyclophosphamide is a cancer (chemotherapeutic) medication. Cyclophosphamide interferes
with the growth of cancer cells and slows their growth and spread in the body.
|
|
Fludarabine is a chemotherapy medicine used to treat certain types of cancer by destroying cancerous cells. It is known as the brand name Fludara.
|
|
Antimetabolite antineoplastic agent; synthetic purine antagonist.
|
|
Fludarabine is a cancer medication that interferes with the growth and spread of cancer
cells in the body.
|
|
Chlorambucil is a cancer medication that interferes with cancer cells and slows their
growth and spread in the body.
|
|
Cladribine is a cancer (antineoplastic) medication. Cladribine interferes with the growth of
cancer cells and slows their growth and spread in the body.
|
|
Mitoxantrone is a cancer (antineoplastic) medication. Mitoxantrone interferes with the growth of
cancer cells and slows their growth and spread in the body. Mitoxantrone also affects the immune
system.
|
|
Antineoplastic agent; a synthetic anthracenedione.
|
|
Mitoxantrone, also known by its trade name Novantrone, is an anticancer agent effective against certain kinds of leukemias. It is also used in Multiple Sclerosis (MS), and was approved by the Federal Drug Administration in 1987.
|
|
Rituximab is a cancer medication that interferes with the growth of cancer cells and slows
their growth and spread in the body.
|
|
Rituximab is a humanized monoclonal antibody that selectively binds to CD20, a protein found on the surface of normal and malignant B cells and is used to reduce the numbers of circulating B cells in patients who have B-cell non-Hodgkin ' s lymphoma (NHL). Rituximab is sold as Rituxan in the United States.
|
|
Antineoplastic agent; a chimeric human-murine anti-human antigen CD20 monoclonal antibody.
|
 |
 |
Home | About | Health Experts | Careers | Site Map | Feedback | Help | Health Tools | Tell a Friend
Advertise | Terms of Use | Privacy Policy
Advertise | Terms of Use | Privacy Policy
Copyright © 2005 - 2008 Healthline Networks, Inc. All rights reserved.